Skip to main content
OpenTrials
Completed

NCT Number: NCT05127187

Estimation of the Prevalence of HIV, Hepatitis C and Hepatitis B Infection Among Detainees in the Nîmes Administrative Detention Center

People in Administrative Detention Centers often come from areas of medium or high HIV, hepatitis C & B endemic, and are often unaware of their serological status. Currently, HIV, hepatitis C & B screening is not systematically performed at the CRA of Nîmes, and when performed, serological tests are used. The main disadvantage of this method is the length of time it takes to obtain the results, with subjects frequently discharged before receiving their results.

To improve the care of these vulnerable persons, the aim of this study is to estimate the prevalence of HIV, hepatitis C and hepatitis B in the detainees of the administrative detention center of Nîmes, by systematically screening with a rapid diagnosis test. In case of a positive rapid diagnosis test test, a serology test will confirm the rapid diagnosis test result.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

HIV Infections Blood-Borne Infections Communicable Diseases DNA Virus Infections Digestive System Diseases Flaviviridae Infections Genital Diseases Hepadnaviridae Infections Hepatitis Hepatitis B Hepatitis C Hepatitis, Viral, Human Immune System Diseases Immunologic Deficiency Syndromes Infections Lentivirus Infections Liver Diseases RNA Virus Infections Retroviridae Infections Sexually Transmitted Diseases Sexually Transmitted Diseases, Viral Urogenital Diseases Virus Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

CHU Nîmes

Nîmes, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • The patient must have given their free and informed oral consent
  • Patient detained in the Nîmes Administrative Detention Center

Exclusion Criterion

  • It is impossible to give the subject informed information

Treatment and study plan

Rapid diagnosis test against HIV and hepatitis C and B

Diagnostic Test

combined Insti VIH® + Toyo VHC®, then First response Ag Hbs tested on capillary blood sample

Primary outcomes

  1. Prevalence of HIV infection in detainees at the Nîmes Administrative Detention Center

    Time frame: Inclusion

    Rapid diagnosis test: Positive/negative

  2. Prevalence of Hepatitis C infection in detainees at the Nîmes Administrative Detention Center

    Time frame: Inclusion

    Rapid diagnosis test: Positive/negative

  3. Prevalence of Hepatitis B infection in detainees at the Nîmes Administrative Detention Center

    Time frame: Inclusion

    Rapid diagnosis test: Positive/negative

Secondary outcomes

  1. Prevalence of co-infections between HIV, Hepatitis C and Hepatitis B

    Time frame: Inclusion

    Yes or no for co-infection (HIV-Hep C / HIV-Hep B / HepC-HepB / Hiv-HepC-HepB)

  2. Participant country of origin

    Time frame: Inclusion

    Country name

  3. Knowledge of HIV, Hep C and Hep B status

    Time frame: Inclusion

    Yes/no

  4. Participant previous transfusion

    Time frame: Inclusion

    Yes/no

  5. Intravenous drug use

    Time frame: Inclusion

    Yes/no

  6. Intranasal drug use

    Time frame: Inclusion

    Yes/no

  7. Shared drug paraphernalia

    Time frame: Inclusion

    Yes/no

  8. Non-protected sexual activity

    Time frame: Inclusion

    Yes/no

  9. Participant with piercings

    Time frame: Inclusion

    If yes, professional done or not

  10. Participant with tattoos

    Time frame: Inclusion

    If yes, professional done or not

  11. Feasibility of screening

    Time frame: End of study (1 year)

    % of subjects with available samples (ie no subject refusal, subjects arriving at weekend or holiday, study not offered on a weekday, technical problem with test interpretation)

  12. Acceptability of the screening

    Time frame: End of study (1 year)

    % of subjects giving samples

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire de Nīmes

Other

Registry information

Acronym: TRODUMCRA

Important dates

Study start
2022
Primary completion
2022
Study completion
2022
First posted
Nov 19, 2021
Registry last updated
Dec 18, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.